ES | EN
A doctor in a white coat smiling during a consultation with a patient

Genetic Testing for Clinics and Hospitals

Expand your diagnostic capabilities with specialty-specific exome sequencing, interpretation by geneticists, and comprehensive clinical reports.

10medical specialties with targeted exome sequencing
>170genetic studies available
3030 business days for DG Exome® delivery
VUSReassessment of pathogenicity classification at 12 months

A diagnostic laboratory serving your patients

All of our studies are based on whole-exome sequencing, which allows us to expand the analysis without repeating the sequencing process.

DG Exome®

Whole-exome sequencing of more than 20,000 genes, which forms the basis of all our diagnostic studies.

DG Exome Trio®

Exome sequencing of the patient and both parents to identify de novo and inherited variants.

DG Clinical Exome®

Analysis of more than 6,000 genes with proven clinical relevance, based on the entire exome.

Targeted exomes

Exome sequencing tailored to each patient's medical specialty and clinical presentation.

Preventive genetics

DG Preventive Studies on Predisposition to Hereditary Cancer and Cardiovascular Disease.

Clinical Report

Comprehensive, with variants classified according to ACMG guidelines and specific clinical recommendations.

Genetic counselling

Our geneticists help you choose the most appropriate test for each patient and interpret the results.

Targeted exomes

Select a specialty to view its studies, the genes included, and the technical specifications.

An earlier diagnosis changes the patient's treatment plan

Exome and genome sequencing identify the genetic cause in more than one-third of children with suspected genetic disorders and, in many cases, lead to changes in their treatment or follow-up care.

4.7 yearsis the average time it takes to diagnose a rare disease in Europe

Source: EURORDIS, Rare Barometer 2024, more than 10,000 patients from 42 countries

Performance of Genetic Testing in Children with Suspected Genetic Disorders

36%of children with suspected genetic disorders receive a diagnosis through exome sequencing, compared to 10% through microarray analysis

Source: Clark et al., npj Genomic Medicine 2018, meta-analysis of 37 studies and 20,068 children

Quality and Clinical Support

Each study follows a validated workflow involving laboratory procedures, bioinformatics, and data interpretation, which is reviewed by external evaluators each year.

Health Registration
Diagnostic Center C.2.5.6/6466, Principality of Asturias
Certifications
ISO 9001:2015 and ISO/IEC 27001:2022, certified by AENOR
External Evaluation
EMQN and GenQA Annual EQA Programs
Validation
Sanger sequencing for low-coverage variants and MLPA for CNVs on request
Re-evaluation of VUS
At 12 months: submit a new report if the classification changes, or notify the doctor if it does not change
Clinical Support
Medical Consultants in Neurology, Neuropediatrics, and Otolaryngology

How to Request a Study

  1. 1

    Inquiry

    Our geneticists will help you choose the most appropriate test for each patient.

  2. 2

    Application

    Online via Genome Lab at
    or using the application form, along with the informed consent form.

    Download sheet
  3. 3

    Sample

    Sample shipping at no additional cost from your facility.

  4. 4

    Report

    Results report interpreted
    by our geneticists.

Shall we talk about your patient?

We'll answer your questions about the most appropriate genetic test or send you a no-obligation quote.

  • Response within 24 business hours
  • Advice from our geneticists on choosing a test
  • Sample shipping at no additional cost from your facility
Thank you. Prototype: The form does not submit data.
Business Communications
Terms of Use and Privacy Policy